Divergent Age-Dependent Conformational Rearrangement within Aβ Amyloid Deposits in APP23, APPPS1, and AppNL-F Mice
Open Access
- 23 April 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 15 (10) , 2058-2069
Abstract
Amyloid plaques composed of fibrils of misfolded Aβ peptides are pathological hallmarks of Alzheimer's disease (AD). Aβ fibrils are polymorphic in their tertiary and quaternary molecular structures. This structural polymorphism may carry different pathologic potencies and can putatively contribute to clinical phenotypes of AD. Therefore, mapping of structural polymorphism of Aβ fibrils and structural evolution over time is valuable to understanding disease mechanisms. Here, we investigated how Aβ fibril structures in situ differ in Aβ plaque of different mouse models expressing familial mutations in the AβPP gene. We imaged frozen brains with a combination of conformation-sensitive luminescent conjugated oligothiophene (LCO) ligands and Aβ-specific antibodies. LCO fluorescence mapping revealed that mouse models APP23, APPPS1, and AppNL-F have different fibril structures within Aβ-amyloid plaques depending on the AβPP-processing genotype. Co-staining with Aβ-specific antibodies showed that individual plaques from APP23 mice expressing AβPP Swedish mutation have two distinct fibril polymorph regions of core and corona. The plaque core is predominantly composed of compact Aβ40 fibrils, and the corona region is dominated by diffusely packed Aβ40 fibrils. Conversely, the AβPP knock-in mouse AppNL-F, expressing the AβPP Iberian mutation along with Swedish mutation has tiny, cored plaques consisting mainly of compact Aβ42 fibrils, vastly different from APP23 even at elevated age up to 21 months. Age-dependent polymorph rearrangement of plaque cores observed for APP23 and APPPS1 mice >12 months, appears strongly promoted by Aβ40 and was hence minuscule in AppNL-F. These structural studies of amyloid plaques in situ can map disease-relevant fibril polymorph distributions to guide the design of diagnostic and therapeutic molecules.Keywords
All Related Versions
Funding Information
- Vetenskapsr?det (2016-00748, 2019-04405)
- Bertil H?llstens Forskningsstiftelse
- Torsten S?derbergs Stiftelse
- Hj?rnfonden (ALZ2019-0004, ALZ2022-0004, FO2020-0207, FO2022-0072)
- Erling-Perssons Stiftelse
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Alzheimer Sverige
This publication has 53 references indexed in Scilit:
- Thiophene‐Based Ligands: Design, Synthesis and Their Utilization for Optical Assignment of Polymorphic‐Disease‐Associated Protein AggregatesChemBioChem, 2023
- Cryo-EM structures of amyloid-β filaments with the Arctic mutation (E22G) from human and mouse brainsActa Neuropathologica, 2023
- Prion strains: shining new light on old conceptsCell and tissue research, 2022
- The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer’s diseaseActa Neuropathologica, 2020
- Detection and Imaging of Aβ1‐42 and Tau Fibrils by Redesigned Fluorescent X‐34 AnaloguesChemistry – A European Journal, 2018
- Anionic Oligothiophenes Compete for Binding of X‐34 but not PIB to Recombinant Aβ Amyloid Fibrils and Alzheimer's Disease Brain‐Derived AβChemistry – A European Journal, 2016
- Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain TissueCell, 2013
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008
- Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responsesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- Alzheimer disease and cerebrovascular pathology: an updateJournal of Neural Transmission, 2002